Life Sciences Times, Author at Boston Life Sciences Times

Revvity Introduces Signals Xynthetica AI Platform for Molecular and Materials Discovery

December 16, 2025

Capital Discipline Matters: Sam Zell’s Lessons for Every Entrepreneur

December 13, 2025

Kymera Therapeutics Closes Upsized $602 Million Public Offering, Underwriters Fully Exercise Option

December 12, 2025

THIS WEEK'S STORIES

EpilepsyGTx raises $33 million Series A to advance single-dose gene therapy for focal refractory epilepsy

December 10, 2025

Insulet Expands Omnipod U.S. Recycling Program Nationwide

December 15, 2025

Survey shows healthcare experts fear AI will accelerate online medical misinformation

December 11, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences Times

TOP AUTHORS

Most Read

Calluna Pharma Appoints Gijs van den Brink, MD, PhD, as Independent Director

Cosette Pharmaceuticals Launches First Generic Version of CIPRO HC Following FDA Approval

nChroma Bio Receives Clinical Trial Authorization to Launch First-in-Human Study of CRMA-1001 for Chronic Hepatitis B

Revvity Introduces Signals Xynthetica AI Platform for Molecular and Materials Discovery

EDITOR PICKS

Revvity Introduces Signals Xynthetica AI Platform for Molecular and Materials Discovery

Capital Discipline Matters: Sam Zell’s Lessons for Every Entrepreneur

Kymera Therapeutics Closes Upsized $602 Million Public Offering, Underwriters Fully Exercise Option

THIS WEEK'S STORIES

EpilepsyGTx raises $33 million Series A to advance single-dose gene therapy for focal refractory epilepsy

Insulet Expands Omnipod U.S. Recycling Program Nationwide

Survey shows healthcare experts fear AI will accelerate online medical misinformation

POPULAR CATEGORY

ABOUT US

FOLLOW US